OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis

HTML

Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: American Journal of Respiratory and Critical Care Medicine
DOI: 10.1164/rccm.201704-0784oc
Authors: Joseph M. Parker, Ian N. Glaspole, Lisa H. Lancaster, Tarik J. Haddad, Dewei She, Stephanie L. Roseti, Jon P. Fiening, Ethan P. Grant, Chris M. Kell, Kevin R. Flaherty
Institutions: The Alfred Hospital, Alfred Health, Monash University, Vanderbilt University, Tampa General Hospital, University of Michigan
Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: tralokinumab, idiopathic pulmonary fibrosis, IL-13, anti-IL-13 monoclonal antibody, forced vital capacity decline, periostin, treatment efficacy, drug safety and tolerability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2744147503
FWCI: 11.6
Cites: 23
Cited by: 136
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security